Patients with MPA and with positivity for MPO-ANCA are predominant in Asian countries, whereas patients with GPA and with positivity for PR3-ANCA are predominant in northern Europe and the United States [6]. This evidence concerns the gene PRTN3 and granulomatosis with polyangiitis.